All In MedTech

Device Trial Radar · NCT07221097

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel - Sponsor's Protocol

Last checked: Nov 20, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

2,091

Actual

Start

Sep 29, 2025

Primary completion

Mar 31, 2026

Study completion Apr 30, 2026

Sponsor

Lead sponsor
BioFire Defense LLCNot on our public-company list
Sponsor type
Industry
Collaborators
Children's Hospital Los Angeles; George Washington University; Wake Forest University Health Sciences; Tampa General Hospital; The University of Texas Medical Branch, Galveston; Emory University
First posted
Oct 27, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Biomedical Advanced Research and Development Authority (BARDA) has contracted BioFire Defense (BFDf) to develop the BioFire Emerging Coronavirus (ECoV) Panel, a nucleic acid test capable of detecting coronaviruses from nasopharyngeal swab (NPS) in transport medium. This study aims to evaluate the diagnostic accuracy of the assays comprising the BioFire ECoV Panel. It is hypothesized that the BioFire ECoV Panel assays will be highly sensitive and specific for the detection of the coronaviruses included on the panel.

Conditions

  • Coronavirus
  • Respiratory Infection
  • COVID

Interventions

  • Investigational IVD for coronavirusesDevice

    Device testing on prospectively collected specimens leftover from standard of care for IVD validation only; results will not influence patient care/management.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Device PerformanceTime frame: Through study completion; September 2025-August 2026

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.